Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(11%)
Results Posted
75%(3 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
2
22%
Ph phase_3
1
11%
Ph not_applicable
5
56%
Ph phase_4
1
11%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Completed4
unknown1
Not yet recruiting1
Recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (22.2%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A5 (55.6%)

Trials by Status

unknown111%
completed444%
not_yet_recruiting111%
recruiting111%
withdrawn111%
terminated111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9